The variant methylenetetrahydrofolate reductase c.1298A > C (p.E429A) is associated with multiple sclerosis in a German case-control study

Neuroscience Letters

Volumn 468, Issue 3, 2010, Pages 183-185

  Klotz, L ^a   Farkas, M ^b   Bain, N ^b   Keskitalo, S ^b   Semmler, A ^b   Ineichen, B ^b   Jelcic, J ^b   Klockgether, T ^a   Kolsch H ^a   Weller, M ^b   Linnebank, M ^b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Case control study; Methylenetetrahydrofolate reductase; Multiple sclerosis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GERMANY; HEREDITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN VARIANT;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MULTIPLE SCLEROSIS, RELAPSING-REMITTING; MUTATION, MISSENSE;

EID: 72249107090     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.10.057     Document Type: Article

References (15)

1. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J., den Heijer M., Kluijtmans L.A., and van den Heuvel L.P. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10 (1995) 111-113
2. International Multiple Sclerosis Genetics C., Hafler D.A., Compston A., Sawcer S., Lander E.S., Daly M.J., De Jager P.L., de Bakker P.I., Gabriel S.B., Mirel D.B., Ivinson A.J., Pericak-Vance M.A., Gregory S.G., Rioux J.D., McCauley J.L., Haines J.L., Barcellos L.F., Cree B., Oksenberg J.R., and Hauser S.L. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 357 (2007) 851-862
3. Linnebank M., Homberger A., Nowak-Gottl U., Marquardt T., Harms E., and Koch H.G. Linkage disequilibrium of the common mutations 677C > T and 1298A > C of the human methylenetetrahydrofolate reductase gene as proven by the novel polymorphisms 129C > T, 1068C > T. Eur. J. Pediatr. 159 (2000) 472-473
4. Linnebank M., Linnebank A., Jeub M., Klockgether T., Wullner U., Kolsch H., Heun R., Koch H.G., Suormala T., and Fowler B. Lack of genetic dispositions to hyperhomocysteinemia in Alzheimer disease. Am. J. Med. Genet. A 131 (2004) 101-102
5. Miller A., Korem M., Almog R., and Galboiz Y. Vitamin B12, demyelination, remyelination and repair in multiple sclerosis. J. Neurol. Sci. 233 (2005) 93-97
6. Oksenberg J.R., Baranzini S.E., Sawcer S., and Hauser S.L. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat. Rev. Genet. 9 (2008) 516-526
7. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., Lublin F.D., Metz L.M., McFarland H.F., O'Connor P.W., Sandberg-Wollheim M., Thompson A.J., Weinshenker B.G., and Wolinsky J.S. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann. Neurol. 58 (2005) 840-846
8. Ramsaransing G.S., Fokkema M.R., Teelken A., Arutjunyan A.V., Koch M., and De Keyser J. Plasma homocysteine levels in multiple sclerosis. J. Neurol. Neurosurg. Psychiatr. 77 (2006) 189-192
9. Reynolds E.H., Bottiglieri T., Laundy M., Crellin R.F., and Kirker S.G. Vitamin B12 metabolism in multiple sclerosis. Arch. Neurol. 49 (1992) 649-652
10. Surtees R., Leonard J., and Austin S. Association of demyelination with deficiency of cerebrospinal-fluid S-adenosylmethionine in inborn errors of methyl-transfer pathway. Lancet 338 (1991) 1550-1554
11. van der Put N.M., Gabreels F., Stevens E.M., Smeitink J.A., Trijbels F.J., Eskes T.K., van den Heuvel L.P., and Blom H.J. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?. Am. J. Hum. Genet. 62 (1998) 1044-1051
12. van Rensburg S.J., Kotze M.J., Hon D., Haug P., Kuyler J., Hendricks M., Botha J., Potocnik F.C., Matsha T., and Erasmus R.T. Iron and the folate-vitamin B12-methylation pathway in multiple sclerosis. Metab. Brain Dis. 21 (2006) 121-137
13. Vrethem M., Mattsson E., Hebelka H., Leerbeck K., Osterberg A., Landtblom A.M., Balla B., Nilsson H., Hultgren M., Brattstrom L., and Kagedal B. Increased plasma homocysteine levels without signs of vitamin B12 deficiency in patients with multiple sclerosis assessed by blood and cerebrospinal fluid homocysteine and methylmalonic acid. Mult. Scler. 9 (2003) 239-245
14. Wade D.T., Young C.A., Chaudhuri K.R., and Davidson D.L. A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and l-phenylalanine (the "Cari Loder regime") in the treatment of multiple sclerosis. J. Neurol. Neurosurg. Psychiatr. 73 (2002) 246-249
15. Wullner U., Kolsch H., and Linnebank M. Methylenetetrahydrofolate reductase in Parkinson's disease. Ann.Neurol. 58 (2005) 972-973